Gary Zeger

431 total citations
19 papers, 315 citations indexed

About

Gary Zeger is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Gary Zeger has authored 19 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Hematology. Recurrent topics in Gary Zeger's work include Colorectal Cancer Treatments and Studies (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Cancer Genomics and Diagnostics (3 papers). Gary Zeger is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Cancer Genomics and Diagnostics (3 papers). Gary Zeger collaborates with scholars based in United States, Germany and Italy. Gary Zeger's co-authors include Martin Maus, Craig Stephens, Stephanie H. Astrow, Eric C. Huang, Peter Grimminger, David R. Gandara, Tianhong Li, Kathleen D. Danenberg, Laurel Beckett and Louise Smith and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology and Transfusion.

In The Last Decade

Gary Zeger

19 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Zeger United States 12 156 151 61 55 48 19 315
Sugganth Daniel United States 7 196 1.3× 96 0.6× 62 1.0× 46 0.8× 70 1.5× 26 313
Débora S. Bruno United States 12 215 1.4× 128 0.8× 51 0.8× 32 0.6× 82 1.7× 45 352
I. Fackler-Schwalbe Germany 4 103 0.7× 29 0.2× 24 0.4× 20 0.4× 23 0.5× 6 308
Emile D. Kerver Netherlands 7 74 0.5× 135 0.9× 26 0.4× 8 0.1× 57 1.2× 10 238
M. Martín Jiménez Spain 10 200 1.3× 133 0.9× 27 0.4× 23 0.4× 79 1.6× 56 323
LT Goodnough United States 9 62 0.4× 28 0.2× 21 0.3× 44 0.8× 15 0.3× 10 394
Lydia Dreosti South Africa 10 300 1.9× 179 1.2× 157 2.6× 33 0.6× 75 1.6× 20 472
Gholamreza Toogeh Iran 10 14 0.1× 52 0.3× 63 1.0× 49 0.9× 31 0.6× 37 353
Thomas Blankenburg Germany 10 208 1.3× 270 1.8× 40 0.7× 34 0.6× 21 0.4× 20 384
Sanders Chang United States 11 114 0.7× 74 0.5× 138 2.3× 109 2.0× 89 1.9× 25 417

Countries citing papers authored by Gary Zeger

Since Specialization
Citations

This map shows the geographic impact of Gary Zeger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Zeger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Zeger more than expected).

Fields of papers citing papers by Gary Zeger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Zeger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Zeger. The network helps show where Gary Zeger may publish in the future.

Co-authorship network of co-authors of Gary Zeger

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Zeger. A scholar is included among the top collaborators of Gary Zeger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Zeger. Gary Zeger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hanna, Diana L., Fotios Loupakis, Dongyun Yang, et al.. (2018). Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study. Clinical Colorectal Cancer. 17(3). e471–e488. 8 indexed citations
2.
Maus, Martin, Diana L. Hanna, Clifton Stephens, et al.. (2014). Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy. The Pharmacogenomics Journal. 15(4). 354–362. 38 indexed citations
3.
Grimminger, Peter, Craig Stephens, Dirk Waldschmidt, et al.. (2014). C-kit mRNA expression in pancreatic adenocarcinoma and matched stromal tissue: Prognostic and therapeutic implications.. Journal of Clinical Oncology. 32(15_suppl). e15185–e15185. 1 indexed citations
4.
Maus, Martin, Craig Stephens, Dirk Waldschmidt, et al.. (2014). C-MET mRNA expression in pancreatic ductal adenocarcinoma and stromal tissue: Prognostic and therapeutic implications.. Journal of Clinical Oncology. 32(15_suppl). e15199–e15199. 3 indexed citations
5.
Maus, Martin, Philip C. Mack, Stephanie H. Astrow, et al.. (2013). Histology-Related Associations of ERCC1, RRM1, and TS Biomarkers in Patients with Non–Small-Cell Lung Cancer: Implications for Therapy. Journal of Thoracic Oncology. 8(5). 582–586. 22 indexed citations
6.
Maus, Martin, Peter Grimminger, Philip C. Mack, et al.. (2013). KRAS mutations in non-small-cell lung cancer and colorectal cancer: Implications for EGFR-targeted therapies. Lung Cancer. 83(2). 163–167. 31 indexed citations
7.
8.
Maus, Martin, Diana L. Hanna, Craig Stephens, et al.. (2013). Gene expression profiles and tumor locations in colorectal cancer (left vs. right vs. rectum).. Journal of Clinical Oncology. 31(15_suppl). 3527–3527. 11 indexed citations
9.
Maus, Martin, Peter Grimminger, Gary Zeger, Craig Stephens, & Eric C. Huang. (2012). Identification of Novel Variant of EML4-ALK Fusion Gene in NSCLC: Potential Benefits of the RT-PCR Method. International Journal of Biomedical Science. 8(1). 1–6. 10 indexed citations
10.
Maus, Martin, Craig Stephens, Gary Zeger, Peter Grimminger, & Eric C. Huang. (2012). Identification of Novel Variant of EML4-ALK Fusion Gene in NSCLC: Potential Benefits of the RT-PCR Method.. PubMed. 8(1). 1–6. 10 indexed citations
11.
Li, Tianhong, Eric C. Huang, Sonal J. Desai, et al.. (2012). Update on the large-scale screening of ALK fusion oncogene transcripts in archival NSCLC tumor specimens using multiplexed RT-PCR assays.. Journal of Clinical Oncology. 30(15_suppl). 7594–7594. 3 indexed citations
12.
Gandara, David R., Eric C. Huang, Sonal J. Desai, et al.. (2012). Thymidylate synthase (TS) gene expression in patients with ALK positive (+) non-small cell lung cancer (NSCLC): Implications for therapy.. Journal of Clinical Oncology. 30(15_suppl). 7582–7582. 15 indexed citations
13.
Jabbour, Nicolas, et al.. (2005). Recombinant Human Coagulation Factor VIIa in Jehovah's Witness Patients Undergoing Liver Transplantation. The American Surgeon. 71(2). 175–179. 15 indexed citations
14.
Girvigian, M.R., et al.. (2004). Squamous Cell Carcinoma Arising in a Second Branchial Cleft Cyst. American Journal of Clinical Oncology. 27(1). 96–100. 22 indexed citations
15.
Kluba, Torsten, et al.. (2004). Untersuchungen zum Schwerpunktlot 15-25 Jahre nach Harrington-Distraktionsspondylodese bei Patienten mit idiopathischer Adoleszentenskoliose. Zeitschrift für Orthopädie und ihre Grenzgebiete. 143(2). 188–193. 4 indexed citations
16.
Arndt, Patricia A., et al.. (1998). An acute hemolytic transfusion reaction caused by an anti‐P1 that reacted at 37°C. Transfusion. 38(4). 373–377. 11 indexed citations
17.
Zeger, Gary, et al.. (1997). Single donor platelets: Can we afford to use them? Can we afford not to use them?. Transfusion Science. 18(4). 585–588. 12 indexed citations
18.
Busch, Martine, Anne M. Guiltinan, Sandra Skettino, et al.. (1991). Safety of blood donations following a natural disaster. Transfusion. 31(8). 719–723. 26 indexed citations
19.
Zeger, Gary, et al.. (1988). Cisplatin‐induced nonimmunologic adsorption of immunoglobulin by red cells. Transfusion. 28(5). 493–495. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sugganth Daniel Breakdown of academic impact, for papers by Débora S. Bruno Breakdown of academic impact, for papers by I. Fackler-Schwalbe Breakdown of academic impact, for papers by Emile D. Kerver Breakdown of academic impact, for papers by M. Martín Jiménez Breakdown of academic impact, for papers by LT Goodnough Breakdown of academic impact, for papers by Lydia Dreosti Breakdown of academic impact, for papers by Gholamreza Toogeh Breakdown of academic impact, for papers by Thomas Blankenburg Breakdown of academic impact, for papers by Sanders Chang
Rankless by CCL
2026